Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid mesotherapy for persistent post-acne erythema
IRCT20190901044666N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tranexamic acid in acne vulgaris and post-acne erythema (PAE), sponsored by Iran University of Medical Sciences. Primary endpoints: Persistent post-acne erythema change and Photographic erythema comparison. Started Aug 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
acne vulgarispost-acne erythema (PAE)
Beyond the preview
Go deeper on IRCT20190901044666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190901044666N1.